{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:18:23Z","timestamp":1794644303962,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000867","name":"Commonwealth Scholarship Commission","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000867","id-type":"DOI","asserted-by":"crossref"}]},{"name":"African Research Network for Neglected Tropical Diseases"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Male genital schistosomiasis (MGS) is hypothesized to increase seminal shedding of HIV-1. This prospective pilot study assessed seminal HIV-1 RNA shedding in men on long-term ART with and without a diagnosis of MGS. Study visits occurred at 0, 1, 3, 6 and 12 months. MGS was diagnosed by egg positivity on semen microscopy or PCR of seminal sediment. After optimization of the HIV-RNA assay, we examined 72 paired plasma and semen samples collected from 31 men (15 with and 16 without MGS) over 12\u00a0months. HIV-1 RNA was detected in 7\/72 (9.7%) seminal samples and 25\/72 (34.7%) plasma samples. When comparing sample pairs, 5\/72 (6.9%) showed HIV-1 RNA detection only in the seminal sample. Overall, 3\/31 (9.7%) participants, all with MGS, had detectable HIV-1 RNA in semen while plasma HIV-1 RNA was undetectable (&lt;\u200922 copies\/mL), with seminal levels ranging up to 400 copies\/mL. Two participants showing HIV-1 RNA in seminal fluid from the MGS-negative group also had concomitant HIV-1 RNA detection in plasma. The findings suggest that MGS can be associated with low-level HIV-1 RNA shedding despite virologically suppressive ART. Further studies are warranted to confirm these observations and assess its implications.<\/jats:p>","DOI":"10.1038\/s41598-023-40756-8","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T16:30:08Z","timestamp":1693326608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prospective pilot study on the relationship between seminal HIV-1 shedding and genital schistosomiasis in men receiving antiretroviral therapy along Lake Malawi"],"prefix":"10.1038","volume":"13","author":[{"given":"Sekeleghe A.","family":"Kayuni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Abdullahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad H.","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Makaula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanuel","family":"Lampiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazarus","family":"Juziwelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. James","family":"LaCourse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnstone J.","family":"Kumwenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Derek Christian","family":"Leutscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Geretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Russell","family":"Stothard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"key":"40756_CR1","unstructured":"(UNAIDS). JUNPoHA. Global HIV Statistics\u20142020 Fact sheet. (Joint United Nations Programme on HIV\/AIDS, Geneva, Switzerland, 2020)."},{"issue":"9936","key":"40756_CR2","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","volume":"383","author":"DG Colley","year":"2014","unstructured":"Colley, D. G., Bustinduy, A. L., Secor, W. E. & King, C. H. Human schistosomiasis. Lancet 383(9936), 2253\u20132264 (2014).","journal-title":"Lancet"},{"issue":"9","key":"40756_CR3","doi-asserted-by":"publisher","first-page":"e0005968","DOI":"10.1371\/journal.pntd.0005968","volume":"11","author":"JA Downs","year":"2017","unstructured":"Downs, J. A. et al. Effects of schistosomiasis on susceptibility to HIV-1 infection and HIV-1 viral load at HIV-1 seroconversion: A nested case-control study. PLoS Negl. Trop. Dis. 11(9), e0005968 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"40756_CR4","unstructured":"WHO. Schistosomiasis Geneva, Switzerland: World Health Organization; 2018 [updated 20th February 2018. Available from: http:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/schistosomiasis."},{"key":"40756_CR5","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.ijid.2020.10.088","volume":"102","author":"P Patel","year":"2020","unstructured":"Patel, P. et al. Association of schistosomiasis and HIV infections: A systematic review and meta-analysis. Int. J. Infect. Dis. 102, 544\u2013553 (2020).","journal-title":"Int. J. Infect. Dis."},{"issue":"17","key":"40756_CR6","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1097\/01.aids.0000191925.54679.94","volume":"19","author":"E Kissling","year":"2005","unstructured":"Kissling, E. et al. Fisherfolk are among groups most at risk of HIV: Cross-country analysis of prevalence and numbers infected. AIDS 19(17), 1939\u20131946 (2005).","journal-title":"AIDS"},{"issue":"2","key":"40756_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1548-1417.2009.01022.x","volume":"30","author":"J Seeley","year":"2009","unstructured":"Seeley, J., Tumwekwase, G. & Grosskurth, H. Fishing for a living but catching HIV: AIDS and changing patterns of the organization of work in fisheries in Uganda. Anthropol. Work. Rev. 30(2), 66\u201376 (2009).","journal-title":"Anthropol. Work. Rev."},{"issue":"6","key":"40756_CR8","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.4269\/ajtmh.2011.11-0135","volume":"85","author":"PM Jourdan","year":"2011","unstructured":"Jourdan, P. M., Holmen, S. D., Gundersen, S. G., Roald, B. & Kjetland, E. F. HIV target cells in schistosoma haematobium-infected female genital Mucosa. Am. J. Trop. Med. Hyg. 85(6), 1060\u20131064 (2011).","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"2","key":"40756_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pt.2011.10.008","volume":"28","author":"EF Kjetland","year":"2012","unstructured":"Kjetland, E. F., Leutscher, P. D. C. & Ndhlovu, P. D. A review of female genital schistosomiasis. Trends Parasitol. 28(2), 58\u201365 (2012).","journal-title":"Trends Parasitol."},{"key":"40756_CR10","doi-asserted-by":"crossref","unstructured":"Kjetland EF, Ndhlovu PD, Gomo E, Mduluza T, Midzi N, Gwanzura L, et al. Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS. 2006;20.","DOI":"10.1097\/01.aids.0000210614.45212.0a"},{"issue":"10","key":"40756_CR11","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1086\/429334","volume":"191","author":"PDC Leutscher","year":"2005","unstructured":"Leutscher, P. D. C. et al. Increased prevalence of leukocytes and elevated cytokine levels in semen from Schistosoma haematobium-infected individuals. J. Infect. Dis. 191(10), 1639\u20131647 (2005).","journal-title":"J. Infect. Dis."},{"issue":"4","key":"40756_CR12","doi-asserted-by":"publisher","first-page":"ofx199","DOI":"10.1093\/ofid\/ofx199","volume":"4","author":"N Midzi","year":"2017","unstructured":"Midzi, N., Mduluza, T., Mudenge, B., Foldager, L. & Leutscher, P. D. C. Decrease in seminal HIV-1 RNA load after praziquantel treatment of urogenital schistosomiasis coinfection in HIV-positive men\u2014An observational study. Open Forum Infect. Dis. 4(4), ofx199 (2017).","journal-title":"Open Forum Infect. Dis."},{"key":"40756_CR13","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/S0140-6736(19)30418-0","volume":"393","author":"AJ Rodger","year":"2019","unstructured":"Rodger, A. J. et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): Final results of a multicentre, prospective, observational study. The Lancet 393, 2428\u20132438 (2019).","journal-title":"The Lancet"},{"issue":"2","key":"40756_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1001\/jama.2016.5148","volume":"316","author":"AJ Rodger","year":"2016","unstructured":"Rodger, A. J. et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA 316(2), 171\u2013181 (2016).","journal-title":"JAMA"},{"issue":"9903","key":"40756_CR15","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/S0140-6736(13)61998-4","volume":"382","author":"MS Cohen","year":"2013","unstructured":"Cohen, M. S. et al. Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: Where do we go from here?. The Lancet. 382(9903), 1515\u20131524 (2013).","journal-title":"The Lancet."},{"issue":"1","key":"40756_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/QAD.0000000000002373","volume":"34","author":"JA Nelson","year":"2020","unstructured":"Nelson, J. A. et al. Female genital tract shedding of HIV-1 is rare in women with suppressed HIV-1 in plasma. AIDS 34(1), 39\u201346 (2020).","journal-title":"AIDS"},{"issue":"13","key":"40756_CR17","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1097\/QAD.0b013e32830abdc8","volume":"22","author":"A-G Marcelin","year":"2008","unstructured":"Marcelin, A.-G. et al. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma. AIDS 22(13), 1677\u20131679 (2008).","journal-title":"AIDS"},{"issue":"15","key":"40756_CR18","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1097\/QAD.0b013e3283303e04","volume":"23","author":"PM Sheth","year":"2009","unstructured":"Sheth, P. M. et al. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy. AIDS 23(15), 2050\u20132054 (2009).","journal-title":"AIDS"},{"issue":"5","key":"40756_CR19","first-page":"579","volume":"72","author":"A Mujugira","year":"2016","unstructured":"Mujugira, A. et al. HIV transmission risk persists during the first 6 months of Antiretroviral therapy. JAMA 72(5), 579 (2016).","journal-title":"JAMA"},{"issue":"9198","key":"40756_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(99)04856-4","volume":"355","author":"P Leutscher","year":"2000","unstructured":"Leutscher, P. et al. Community-based study of genital schistosomiasis in men from Madagascar. The Lancet 355(9198), 117\u2013118 (2000).","journal-title":"The Lancet"},{"key":"40756_CR21","unstructured":"WHO. Malawi: HIV Country Profile 2022. HIV Country Intelligence. (WHO, Geneva, Switzerland, 2022)."},{"key":"40756_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40249-015-0053-1","volume":"4","author":"AH Mtethiwa","year":"2015","unstructured":"Mtethiwa, A. H., Nkwengulila, G., Bakuza, J., Sikawa, D. & Kazembe, A. Extent of morbidity associated with schistosomiasis infection in Malawi: A review paper. Infect. Dis. Poverty 4, 25 (2015).","journal-title":"Infect. Dis. Poverty"},{"key":"40756_CR23","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1017\/S0031182019000969","volume":"146","author":"SA Kayuni","year":"2019","unstructured":"Kayuni, S. A. et al. How can schistosome circulating antigen assays be best applied for diagnosing male genital schistosomiasis (MGS): An appraisal using exemplar MGS cases from a longitudinal cohort study among fishermen on the south shoreline of Lake Malawi. Parasitology 146, 1785\u20131795 (2019).","journal-title":"Parasitology"},{"key":"40756_CR24","doi-asserted-by":"publisher","first-page":"590695","DOI":"10.3389\/fpubh.2021.590695","volume":"9","author":"SA Kayuni","year":"2021","unstructured":"Kayuni, S. A. et al. Male genital schistosomiasis along the Shoreline of Lake Malawi: Baseline prevalence and associated knowledge, attitudes and practices among local fishermen in Mangochi District Malawi. Front. Public Health 9, 590695 (2021).","journal-title":"Front. Public Health"},{"key":"40756_CR25","doi-asserted-by":"publisher","first-page":"100231","DOI":"10.1016\/j.eclinm.2019.12.001","volume":"18","author":"G Villa","year":"2020","unstructured":"Villa, G. et al. Determining virological suppression and resuppression by point-of-care viral load testing in a HIV care setting in sub-Saharan Africa. EClinicalMedicine. 18, 100231 (2020).","journal-title":"EClinicalMedicine."},{"key":"40756_CR26","unstructured":"Cepheid. Xpert HIV-1 Viral Load United States of America2018 [22\/11\/2019]. Available from: https:\/\/www.cepheid.com\/en\/cepheid-solutions\/clinical-ivd-tests\/virology\/xpert-hiv-1-viral-load."},{"key":"40756_CR27","unstructured":"Xpert HIV-1 QUAL datasheet. [Internet]. 2018. Available from: https:\/\/p.cdn.net\/sde8xc\/Cepheid-Xpert_hiv_1_qual_Brochure_CE-IVD-3053_English."},{"key":"40756_CR28","unstructured":"WHO. WHO Prequalification of in Vitro Diagnostics. Public report product: Xpert HIV Qual assay WHO reference number: PQDx 0259-070-00. (World Health Organization, Geneva, Switzerland, 2017)"},{"issue":"7","key":"40756_CR29","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/S1473-3099(14)70001-5","volume":"14","author":"A Bustinduy","year":"2014","unstructured":"Bustinduy, A. et al. HIV and schistosomiasis co-infection in African children. Lancet. Infect. Dis 14(7), 640\u2013649 (2014).","journal-title":"Lancet. Infect. Dis"},{"issue":"9","key":"40756_CR30","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1600693","volume":"375","author":"MS Cohen","year":"2016","unstructured":"Cohen, M. S. et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N. Engl. J. Med. 375(9), 830\u2013839 (2016).","journal-title":"N. Engl. J. Med."},{"key":"40756_CR31","doi-asserted-by":"publisher","first-page":"ofac148","DOI":"10.1093\/ofid\/ofac148","volume":"9","author":"JJ van Oosterhout","year":"2022","unstructured":"van Oosterhout, J. J. et al. Dolutegravir resistance in Malawi\u2019s National HIV treatment program. Open Forum Infect. Dis. 9, ofac148 (2022).","journal-title":"Open Forum Infect. Dis."},{"key":"40756_CR32","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1093\/jac\/dkad195","volume":"78","author":"A Abdullahi","year":"2023","unstructured":"Abdullahi, A. et al. Limited emergence of resistance to integrase strand transfer inhibitors (INSTIs) in ART-experienced participants failing dolutegravir-based antiretroviral therapy: A cross-sectional analysis of a Northeast Nigerian cohort. J. Antimicrob. Chemother. 78, 2000\u20132007 (2023).","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40756-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40756-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40756-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T11:13:43Z","timestamp":1700306023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40756-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["40756"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-40756-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1526221\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-1526221\/v2","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,29]]},"assertion":[{"value":"12 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AMG has received personal fees from Abbott, Gilead, GSK, Roche, and ViiV and research funding (to the Institution) from Roche and ViiV, while A.A is supported by the Takemi Program in International Health at the Harvard T.H. Chan School of Public Health,\u00a0outside of the work presented. All the other authors have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14154"}}